Earnings Call · Q1 FY2026·2026-05-13

Q1 26EPS +7.14%·Rev n/aQ4 25EPS +20.77%·Rev n/aQ3 25EPS +5.00%·Rev n/aQ2 25EPS +8.70%·Rev n/a⚠ consensus missing

PDS Biotechnology Corp PDSB

Unknown Attendee — Host/Moderator

Frank Bedu-Addo — President/CEO

Kirk Shepard — Chief Medical Officer

Lars Boesgaard — Chief Financial Officer

+20.9%1d on move date+20.3% vs SPY3d+21.8%5d−9.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PDSB calls or request research access.

More PDSB calls Browse calls Request research access